apolipoprotein C3
| GO Term | Evidence Code | PMID |
|---|---|---|
| triglyceride metabolic process | ||
| G protein-coupled receptor signaling pathway | ||
| negative regulation of triglyceride catabolic process | ||
| negative regulation of triglyceride catabolic process | ||
| negative regulation of very-low-density lipoprotein particle remodeling |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular space | ||
| early endosome | ||
| very-low-density lipoprotein particle | ||
| very-low-density lipoprotein particle |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding | ||
| phospholipid binding | ||
| phospholipid binding | ||
| cholesterol binding | ||
| enzyme regulator activity |
| InterPro |
|---|
| Apolipoprotein CIII superfamily |
| Apolipoprotein CIII |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111370 | apolipoprotein C-III deficiency | |
| DOID:10603 | glucose intolerance | |
| DOID:13809 | familial combined hyperlipidemia | |
| DOID:1561 | cognitive disorder | |
| DOID:3145 | hyperlipoproteinemia type III | |
| DOID:3393 | coronary artery disease | |
| DOID:684 | hepatocellular carcinoma | |
| DOID:784 | chronic kidney disease | |
| DOID:9744 | type 1 diabetes mellitus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026